Trilogy Capital’s Humacyte HUMA Stock Holding History

Trilogy Capital’s Portfolio HUMA Stock Details HUMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.3K	Sell	17,050 -20,750	-55%	-$19.2K	﹤0.01%	403
2026 Q1	$22.9K	Sell	37,800 -17,000	-31%	-$17.7K	﹤0.01%	389
2025 Q4	$52.6K	Sell	54,800 -75,000	-58%	-$106K	﹤0.01%	382
2025 Q3	$226K	Hold	129,800	–	–	0.01%	360
2025 Q2	$271K	Sell	129,800 -40,000	-24%	-$76.8K	0.01%	305
2025 Q1	$290K	Buy	169,800 +86,300	+103%	+$324K	0.02%	286
2024 Q4	$422K	Buy	+83,500	New	+$413K	0.02%	244

Other funds holding HUMA

United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return

Clarus Wealth Advisors Peoria, Arizona $260M AUM 27.97% 1-Year Est. Return

V.M. Manning & Co Greenville, South Carolina $117M AUM

Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Brookstone Capital Management Wheaton, Illinois $9.96B AUM 23.61% 1-Year Est. Return

Clearview Wealth Management Irvine, California $156M AUM

Key Client Fiduciary Advisors Fairfield, New Jersey $343M AUM 35.3% 1-Year Est. Return